Decision allows continued sale and use of product held by distributors and growers
RESEARCH TRIANGLE PARK, N.C. (April 7, 2010) — The Environmental Protection Agency (EPA) announced on April 5 that existing stocks of spirotetramat, the active ingredient in MoventoTM, UltorTM and KontosTM insecticides, may continue to be distributed and used within the normal channels of trade.
EPA acknowledged that the registrations had been cancelled “because of judicial action related to a procedural failure on the part of the Agency,” and not because of any risk concerns associated with the product. Based on its review of hundreds of scientific studies, and after considering public comments submitted concerning existing stocks, EPA reconfirmed its conclusion that there are “no significant risk concerns associated with spirotetramat.” In fact, EPA concluded that “spirotetramat has a more favorable risk profile in terms of human health and the environment than the registered alternatives.”
Furthermore, EPA rejected recent suggestions by the Natural Resources Defense Council that spirotetramat use might pose a threat to honey bees, finding such claims unsupported by scientific data. The Agency’s favorable assessment of spirotetramat was based on numerous studies of its safety to honey bees and other important pollinators.
EPA noted that nearly 90% of the public comments received in response to the Agency’s solicitation of public input requested the continued use and distribution of existing stocks of spirotetramat. Such comments included the need for spirotetramat as a “reduced risk” pesticide and as an important tool in integrated pest management (IPM) programs. Many growers noted that spirotetramat is vital in their struggle against invasive species and is more selective and less injurious to beneficial insects than alternative insecticides.
“We are pleased that EPA’s decision has reaffirmed our assessment of spirotetramat as an important IPM tool in the fight against destructive pests” said Kevin Adam, Product Manager for Bayer CropScience. “We will continue to work with the Agency and remain hopeful that the full registrations will be reinstated in the near future.”
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience AG, a subsidiary of Bayer AG with annual sales of about EUR 6.5 billion (2009), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 18,700 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports, which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Please Contact Us for additional information